Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1018P (RNA, U6 small nuclear 1018, pseudogene) is classified as a pseudogene of the U6 small nuclear RNA (snRNA) family. Pseudogenes are non-functional genomic DNA sequences similar to normal genes but typically lack the capacity to encode proteins or functional RNA due to mutations or lack of regulatory elements[6]. U6 snRNAs themselves play a critical role in the spliceosome machinery, mediating pre-mRNA splicing in eukaryotic cells[1][3], but pseudogenes like RNU6-1018P are considered non-functional and do not participate in those processes[4][5]. There is no evidence to suggest any physiological, pathological, or drug interaction roles for RNU6-1018P. Like other small nuclear RNA pseudogenes, it is best understood as a genomic remnant of an ancestral U6 RNA gene copy, and is not a therapeutic target nor associated with disease, function, or direct biomarker utility[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1018, pseudogene (RNU6-1018P).